HOME >> MEDICINE >> NEWS
GSK announces launch of largest ever Phase III trial in lung cancer treatment

Chicago - June 5th, 2007 GlaxoSmithKline (GSK) today announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC). These data were presented at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, [Abstract No: 7554]. Final trial analysis showed a 27% reduction in the relative risk of cancer recurrence following surgery in patients treated with the MAGE-A3 ASCI, compared to placebo.

Final results from this trial confirm the positive interim results released last year at ASCO 2006, and support expanded testing of this novel cancer immunotherapy, said Paul A. Bunn Jr., M.D., James Dudley Endowed Professor of Oncology, Professor of Medicine and Director of the University of Colorado Cancer Center, Aurora, Colorado. This approach represents a potentially momentous shift in the cancer treatment paradigm. I believe we have only just scratched the surface of what is possible and look forward to seeing the results of the Phase III trial in due course.

Based on these encouraging data, GSK also announced today the opening of patient recruitment to the randomized and controlled Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MAGE-A3 positive patients with completely resected stage IB, II or IIIA NSCLC.

GSKs ASCIs aim to stimulate the patients own immune response to identify and attack cancer cells in a highly specific manner. This novel cancer immunotherapy is developed using tumor specific antigens, delivered as highly purified recombinant proteins, and GSKs own proprietary Adjuvant Systems, which are specifically designed to enhance ASCIs anti-tumor activity

Phase
'"/>

Contact: Andrea Long
andreal@wagged.com
202-326-0791
GlaxoSmithKline Biologicals
5-Jun-2007


Page: 1 2 3

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. AstraZeneca announces SYMBICORT is now available in the US
3. Weill Cornell Medical College announces gifts totaling $400M
4. Elsevier announces launch of Brain Stimulation
5. NSW Premier announces $15M for childrens cancer research
6. National Inventors Hall of Fame announces 2007 inductees
7. Emory University announces new Global Health Institute
8. BioMed Central announces Journal of Medical Case Reports
9. Tibotec Therapeutics announces start of largest US study on HIV treatment in women
10. Wiley announces partnership with NASPGHAN and AASLD
11. W.M. Keck Foundation announces 2006 class of Distinguished Young Scholars in Medical Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... cloud-based business management solution for chiropractors, announced today the launch of its integrated, ... professionals can start running their virtual practice in under 90 seconds. , ...
(Date:8/31/2020)... ... ... for Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time in ... deep anxiety, immense stress, and right now are needing serious relief from a constant state ... planet are experiencing a great degree of emotional discomfort, be it fear or worrying about ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy ... ease than most people would. Rather than become melancholic, however, he put together a ... achieving one’s dreams. Randy Pausch took a negative situation and turned it into something ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... set out to continue helping the specialty-diet community connect with great, gluten-free ... products, get coupons, enter giveaways, chat with brands & watch over 50 educational ...
(Date:8/27/2020)... N.Y. (PRWEB) , ... August 27, 2020 , ... ... DePinto, has joined the Walk-in Dermatology team in its Greenvale, New York location. ... Island Nail and Skin Care Institute. She is certified in chemical peels, microdermabrasion, ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... ... ... U.S. Dermatology Partners is excited to welcome Board-Certified Dermatologist and Fellowship-Trained ... Dermatopathology Lab. , Jonathan Lee, MD grew up in the California Bay Area ... to receive his M.D. with Honors from Harvard Medical School and pre-doctoral surgical pathology ...
(Date:9/1/2020)... ... September 01, 2020 , ... While coronavirus cases continue to increase across the ... community organizations remain closed. Because about 80% of blood donations are made at drives ... donors and blood drive hosts to ensure blood products are readily available for patients. ...
(Date:8/31/2020)... ... August 31, 2020 , ... If you live in New York City you will ... part makes sense, it’s the law of supply and demand, but are plastic surgeons in ... a significant percentage of their patients that make the four-hour trip to have expert aesthetic ...
Breaking Medicine Technology:
Cached News: